Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock

It's been over a year since I covered Fulgent Genetics ( FLGT ), a biotech company focusing on cancer cures. On my first look, I saw a company trading significantly below the net value ofI am a software developer by trade who focuses on finding value in the market wherever it may lie. I'm looking mainly in small caps for opportunities that provide asymmetric upside. I'm also interested in generating income through my investments, which leads me to look at high dividend yields that are sustainable. Things I ...